BSG and neoplasm: We report that the disruption of BSG decreased the expression and activity of MCT1 and MCT4, decreased the rate of glycolysis, increased the rate of respiration and sensitized the three BSG−/− tumour cell lines to the inhibition of OXPHOS by metformin/phenformin (mitochondrial complex I inhibitors) in vitro and in vivo.